FDA granted Exact Sciences’ DNA methylation based liquid biopsy test Breakthrough Device designation for detection of hepatocellular carcinoma, based on recently presented data.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
